Study on pharmacokinetics of remifentanil in children

Solid-Phase Extraction Combined with UPLC-MS/MS Method for Determination of Remifentanil in Children Whole Blood

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR-OCS-13004722

Enrollment

Unknown

Registered

2013-09-18

Start date

2014-04-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Children's surgical diseases

Interventions

case series:remifentanil

Eligibility

Sex/Gender

Male

Age

1 Years to 6 Years

Inclusion criteria

Inclusion criteria: (1) ASA I, II; (2) Aged 1m to 6 years male or female; (3) Operation time >1hRequire general anesthesia endotracheal intubation; (4) After checking the heart, lung, liver and kidney function were normal; (5) No cholinesterase abnormal medical history and family history; (6) No long-term use of opioids History; (7) Agree to participate in this study, and signed informed consent.

Exclusion criteria

Exclusion criteria: (1) weight more than the standard weight of +/-25%; (2) Opioid adverse reactions History; (3) A history of opioid treatment and 6 months participated in similar Researchers.

Design outcomes

Primary

Measure	Time frame
pharmacokinetic parameter;	—

Contacts

Public ContactQingquan Lian

The 2nd Affiliated Hospital of Wenzhou Medical University, Department of Anesthesiology

lianqingquanmz@163.com+86 13957713889

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026